Bayrak-Toydemir, P., Mao, R., Lewin, S. and McDonald, J. (2004) Hereditary Hemorrhagic Telangiectasia: An Overview of Diagnosis and Management in the Molecular Era for Clinicians. Genetics in Medicine, 6, 175-191.
http://dx.doi.org/10.1097/01.GIM.0000132689.25644.7C

has been cited by the following article:

• TITLE: Novel ACLV1 Mutation Identified in Late Onset Hereditary Hemorrhagic Telangiectasia

  AUTHORS: Cory Patrick, Kaitlin McIntyre, Jeremy Ramidial, Sano Joa, Vijaykumar Dinsukhlal Zaveri, Damien Hansra

  KEYWORDS: Hereditary Hemorrhagic Telaniectasia, Osler-Weber-Rendu Syndrome, Anemia, Mutation

  JOURNAL NAME: International Journal of Otolaryngology and Head & Neck Surgery, Vol.5 No.4, July 18, 2016

  ABSTRACT: Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant disorder with variable expressivity. We present a 62-year-old patient with a rare, late-onset disease course featuring a novel mutation in ACVRL1, a signal transducer in the TGFβ/BMP pathway.